Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers Results available

Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism

ClinicalTrials.gov ID: NCT03681808

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03681808. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism Soft Contact Lens When Worn on a Daily Basis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Comparing Test Lens for Astigmatism Soft Contact Lens (Test) to 1-Day Control for Astigmatism contact lenses (Control).

Study identification

NCT ID
NCT03681808
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
242 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2018 (Actual)
Primary completion
Dec 16, 2019 (Actual)
Completion
Dec 16, 2019 (Actual)
Last update posted
Jan 8, 2021

2018 – 2019

United States locations

U.S. sites
13
U.S. states
7
U.S. cities
12
Facility City State ZIP Site status
Bausch Site 117 Irvine California 92618 —
Bausch Site 107 San Diego California 92123 —
Bausch Site 101 San Francisco California 94112 —
Bausch Site 108 San Jose California 95132 —
Bausch Site 104 Sunnyvale California 94087 —
Bausch Site 102 Jacksonville Florida 32250 —
Bausch Site 116 Bloomington Illinois 61701 —
Bausch Site 110 Brighton New York 14618 —
Bausch Site 118 New York New York 10022 —
Bausch Site 111 New York New York 10036 —
Bausch Site 114 Raleigh North Carolina 27603 —
Bausch Site 105 Houston Texas 77204 —
Bausch Site 115 Issaquah Washington 98027 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03681808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2021 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.